KREBSBIO / NSE / Biotechnology & Drugs
Krebs Biochemicals & Industries Ltd
1Y Price Trend
Key Information
Recommendations
Target High113.9
Target Low38.52
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk62.47
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Krebs Biochemicals & Industries Ltd Reports Flat Quarterly Performance Amid Prolonged Downtrend Markets Mojo
Krebs Biochemicals & Industries Ltd is Rated Strong Sell Markets Mojo
Krebs Biochemicals & Industries Ltd Locks at Upper Circuit With 4.78% Gain — Buyers Queue, Sellers Absent Markets Mojo
Krebs Biochemicals & Industries Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent Markets Mojo
A 5% Single-Day Surge Takes Krebs Biochemicals & Industries Ltd to Its Upper Circuit Limit of Rs 61.81 Markets Mojo
Krebs Biochemicals FY26 Loss Narrows to ₹1,693.31 lacs scanx.trade
Krebs Biochemicals & Industries Ltd is Rated Strong Sell Markets Mojo
Krebs Biochemicals & Industries reports standalone net loss of Rs 2.34 crore in the March 2026 quarter Business Standard
© SharekeyX | Rusaka Technologies 2024-2026

